Remote Assessment of Signs and Symptoms in Palliative Care

NCT ID: NCT06587321

Last Updated: 2025-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-04-01

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Digital health interventions, including remote monitoring of patients, have been identified as a possible way to address current problems within the health service, including insufficient numbers of staff, and an increasing number of patients requiring services.

The aim of this study is to assess the feasibility of using remote monitoring for patients who are receiving palliative care and to see whether remote monitoring can improve care and outcomes for patients and their families.

Participants in this study will complete regular (daily, weekly, monthly) questionnaires online about how they are feeling. They will also be given equipment to measure their vital signs every day. The clinical team will have access to the results and be able to respond to any new problems as they arise. Patients and their carers will then complete a questionnaire at one month to assess satisfaction with the use of remote monitoring.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Palliative Care Vital Signs Remote Monitoring

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary diagnosis of advanced cancer or another life-limiting condition
* Estimated prognosis greater than 3 months
* Referred for community-based specialist palliative care
* Living in own home (or home of family carer)
* Living with a family carer

Exclusion Criteria

* Estimated prognosis less than 3 months or more than 12 months
* Cognitive impairment - unable to provide consent / complete assessments
* Non-English speaker
* Living in care home / nursing home / hospice / community hospital
* Not living with a family carer
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Our Lady's Hospice and Care Services

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof Andrew Davies

Professor of Palliative Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jenny Power

Role: PRINCIPAL_INVESTIGATOR

Our Lady's Hospice & Care Services

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Our Lady's Hospice & Care Services

Dublin, Dublin, Ireland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Ireland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gemma O'Keeffe

Role: CONTACT

01 406 8700 ext. 6235

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jenny Power

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RS23-078

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.